Landmark Alzheimer’s drug approval confounds research community

Landmark Alzheimer’s drug approval confounds research community

Nature, Published online: 08 June 2021; doi:10.1038/d41586-021-01546-2

Many scientists say there is not enough evidence that Biogen’s aducanumab is an effective therapy for the disease.Landmark Alzheimer’s drug approval confounds research community
Source: Nature